Cost-utility analysis of diabetic foot ulcer treatment in Norway

Research objective


To determine the cost-effectiveness of Integra Dermal Regeneration Template® in
conjunction with the standard care compared to the standard care alone in management of
non-healing neuropathic DFUs in Norwegian setting.


Methods
A Markov state model was designed to compare the costs and the health effects from health care provider’s perspective of IDRT® adjunct to standard care to those of standard care alone over 3 years period. Transition probabilities were used from secondary literature that was based on synthesized clinical trial results, while costs were based on average estimates of resource utilization in Norway.

TSD

  • Ja

Biobank

  • Nei

Godkjenninger

Intern fremleggelse - Ja

Godkjent av: masteroppgavekomiteen

REK - Ikke behov

bruker tall fra litteraturen, ingen individdata

Prosjektleder / prosjektansvarlig ved UiO

Hans Olav Melberg

Ansvarlig enhet

Avdeling for helseledelse og helseøkonomi

Forskere

Prosjekttype

  • Ph.d.-prosjekt

Helsefaglig forskning

  • Ja

Personopplysninger

  • Ikke besvart

Tidsperiode

  • Start: januar 2018
  • Slutt: juli 2018